Sclerosing Peritonitis -The Contribution of Chlorhexidine in Alcohol
Authors:
Open Access
- 1 April 1985
- journal article
- research article
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 5 (2) , 101-104
Abstract
Sclerosing peritonitis now is recognized as an extremely serious complication of peritoneal dialysis. In Glasgow II of 162 patients on CAPD developed sclerosing peritonitis. All 11 came from a group of 54 patients, who used a connecting system that allowed small quantities of the antiseptic spray, chlorhexidine in alcohol, to enter the abdomen. Experiments showed that I ml of this solution added to 2 litres of dialysate produced up to a 20. fold increase in the particle count of the dialysate. Scanning electron microscopy suggested that these particles probably were plastic. In rats intraperitoneal injections of a mixture of antiseptic spray and dialysate produced an inflammatory reaction in the submesothelial tissues, which might represent the early changes of a fibrotic process. To prevent possible longterm complications such as sclerosing peritonitis we should avoid the introduction into the peritoneal cavity of any unnecessary substance and in particular chlorhexidine in alcohol.Keywords
This publication has 8 references indexed in Scilit:
- Survey of Continuous Ambulatory Peritoneal Dialysis in the United Kingdom, 1982Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 1984
- Beta-adrenergic blockade and the gastrointestinal systemThe American Journal of Medicine, 1983
- Propranolol, oxprenolol, and sclerosing peritonitis.BMJ, 1982
- Peritoneal SclerosisArchives of internal medicine (1960), 1981
- Sclerosing Peritonitis and PropranololChest, 1981
- Renal Effects of FenoprofenAnnals of Internal Medicine, 1980
- Sclerosing Peritonitis and PropranololArchives of internal medicine (1960), 1978
- SCLEROSING PERITONITIS, AN UNUSUAL REACTION TO A β-ADRENERGIC-BLOCKING DRUG (PRACTOLOL)The Lancet, 1974